Adaptive Biotechnologies Corp (ADPT) — Cash Flow Quality Index
Latest as of September 2025:
-0.75x
Adaptive Biotechnologies Corp (ADPT) has a Cash Flow Quality Index of -0.75x as of September 2025. Operating cash flow of $-7.13 Million is below net income of $9.55 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Adaptive Biotechnologies Corp strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-0.75x
Operating CF / Net Income
Operating Cash Flow
$-7.13 Million
USD
Net Income
$9.55 Million
USD
Data as of
Sep 2025
Most recent filing
Annual Cash Flow Quality Index for Adaptive Biotechnologies Corp (None–None)
Year-by-year earnings quality comparison for Adaptive Biotechnologies Corp. For live market cap and the full company financial profile, see market value of Adaptive Biotechnologies Corp.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.